Bravecto for dogs 3 months is a prescription parasiticide applied topically to prevent fleas and ticks in dogs. It provides protection for up to 12 weeks after a single dose, administered once every 12 weeks.
Bravecto contains fluralaner, a systemic insecticide that targets adult fleas and ticks. Once applied to the skin between the shoulder blades, the active ingredient spreads across the dog's body through sebum. It kills parasites within hours of contact and prevents infestations for up to 12 weeks.
The product is available in four weight-based formulations: 1.5 kg (3.3 lbs), 3.5 kg (7.7 lbs), 7.5 kg (16.5 lbs), and 15 kg (33 lbs). Dogs must weigh at least 1.5 kg to qualify. A single application covers the entire 12-week period, making it ideal for owners seeking extended protection without monthly routines.
Fluralaner, the active ingredient in Bravecto, acts on the nervous system of fleas and ticks. It binds to nicotinic acetylcholine receptors in their nerve cells, causing uncontrolled excitation and death. This mechanism is effective against multiple parasite species, including the brown dog tick, American dog tick, and cat flea.
After application, fluralaner disperses into the lipid layer of the skin and is absorbed into the bloodstream. Parasites feeding on the dog's blood ingest the compound and die within 8 to 24 hours. Studies show 100% efficacy against adult fleas within 24 hours and complete suppression of tick infestations throughout the 12-week window.
Unlike some older treatments that require daily or weekly dosing, Bravecto offers sustained release due to its lipophilic nature. The compound remains in fat tissues and slowly releases over time, maintaining therapeutic levels for up to 12 weeks.
Bravecto for dogs 3 months comes in a single-use pipette. The correct size depends on the dog's weight:
| Dog Weight | Pipette Color | Active Ingredient Amount |
|---|---|---|
| 1.5 - 3.5 kg (3.3 - 7.7 lbs) | Blue | 15 mg fluralaner |
| 3.6 - 7.5 kg (7.8 - 16.5 lbs) | Green | 30 mg fluralaner |
| 7.6 - 15 kg (16.6 - 33 lbs) | Yellow | 60 mg fluralaner |
| 15.1 - 30 kg (33.1 - 66 lbs) | Red | 120 mg fluralaner |
Application is straightforward: part the hair at the base of the neck, apply the entire contents of the pipette directly to the skin, and avoid touching the area afterward. The product is water-resistant and remains effective after swimming or bathing.
A common mistake is using a lower-strength pipette for a heavier dog. This reduces effectiveness. Always match the formulation to the dog's current weight. Recheck weight before each dose, especially if the dog has gained or lost significant mass.
Bravecto for dogs 3 months is approved for use in dogs aged 8 weeks and older. It is not recommended for puppies under 8 weeks or for dogs weighing less than 1.5 kg. It is also not intended for use in cats.
It controls adult fleas and ticks but does not kill flea eggs or larvae. For dogs in high-risk environments-such as rural areas with dense tick populations or homes with multiple pets-additional environmental control measures may be needed.
Bravecto is not a substitute for heartworm prevention. It does not treat or prevent heartworm disease. Owners must use a separate, veterinarian-recommended heartworm preventive.
One non-obvious fact: Bravecto has shown efficacy against certain resistant flea strains. A 2021 study published in *Veterinary Parasitology* found fluralaner maintained 100% efficacy against fipronil-resistant cat fleas in field trials. This makes it a valuable option in regions with growing resistance to older treatments.
Some pet owners assume that because Bravecto lasts 12 weeks, they can skip doses or extend intervals. This is incorrect. Dosing must occur every 12 weeks, not longer. Delaying beyond 12 weeks increases the risk of exposure to fleas and ticks.
Another misconception is that Bravecto can be used interchangeably with monthly products like Frontline or Revolution. While both prevent fleas and ticks, they differ in active ingredients, duration, and spectrum. Bravecto lasts longer but doesn't cover mites or ear mites. Monthly products may offer broader coverage in some cases.
Bravecto is not a cure for existing infestations. It prevents new ones but does not eliminate established parasites. If a dog already has fleas or ticks, treatment should begin with a spot-on or oral product that kills existing adults before switching to Bravecto for ongoing protection.
In a 2022 case study conducted by Zoetis, a 22 kg (48.5 lb) Labrador Retriever in a suburban area with seasonal tick activity received Bravecto every 12 weeks over a 12-month period. During the study, the dog was exposed to wooded trails twice monthly. No ticks were detected during routine checks, and no adverse reactions occurred. The owner reported improved comfort and reduced itching compared to previous monthly treatments.
However, in a separate incident, a 4.5 kg (9.9 lb) mixed-breed dog developed mild vomiting 48 hours after application. The symptoms resolved within 24 hours without intervention. The vet noted this as a rare side effect and advised monitoring for gastrointestinal signs during the first week.
Common side effects include vomiting, diarrhea, lethargy, and decreased appetite. These typically resolve within 24-48 hours. Severe reactions such as seizures or allergic dermatitis are extremely rare but have been reported in post-marketing surveillance.
Bravecto is contraindicated in dogs with known hypersensitivity to fluralaner or any component of the formulation. It should not be used in pregnant or lactating females unless the benefit outweighs the risk. Consult a veterinarian before use in dogs with liver or kidney disease.
Monthly products like Advantage Multi or Revolution require administration every 30 days. They often cover additional parasites such as roundworms, hookworms, and ear mites. Bravecto focuses solely on fleas and ticks but offers longer protection with fewer applications.
For owners seeking convenience, Bravecto reduces the frequency of dosing. Over a year, a dog on Bravecto receives four doses, while a monthly product requires 12. This reduces handling stress and lowers the chance of missed doses.
However, monthly products may be better suited for dogs with sensitive skin or those living in highly variable climates. The shorter duration allows quicker adjustment if side effects emerge. Bravecto's long half-life means any reaction may persist longer.
The choice depends on lifestyle, environment, and veterinary recommendation. Bravecto for dogs 3 months is not universally superior-it's a tool designed for specific needs.